相似文献
1
Absorption of beta-adrenoceptor antagonists to Amberlite resin.β-肾上腺素受体拮抗剂在Amberlite树脂上的吸附作用。
Br J Clin Pharmacol. 1983 Apr;15(4):490-2. doi: 10.1111/j.1365-2125.1983.tb01535.x.
2
Interaction in healthy volunteers between prenalterol, a selective beta 1-adrenoceptor agonist, and metoprolol or propranolol.选择性β1肾上腺素能受体激动剂普瑞特罗与美托洛尔或普萘洛尔在健康志愿者体内的相互作用。
J Cardiovasc Pharmacol. 1981 May-Jun;3(3):477-84. doi: 10.1097/00005344-198105000-00007.
3
Beta-adrenoceptor blocker intoxication: epidemiological data. Prenalterol as an alternative in the treatment of cardiac dysfunction.β-肾上腺素受体阻滞剂中毒：流行病学数据。普瑞特罗作为治疗心功能不全的替代药物。
Hum Toxicol. 1983 Apr;2(2):175-81. doi: 10.1177/096032718300200202.
4
Prenalterol: a partial beta 1-adrenoceptor agonist or a beta-blocker with intrinsic activity?普瑞纳洛尔：是部分β1肾上腺素能受体激动剂还是具有内在活性的β受体阻滞剂？
Int J Clin Pharmacol Ther Toxicol. 1985 Jan;23(1):20-7.
5
The role of beta- and alpha-adrenoceptors in the regulation of the stages of the sleep-waking cycle in the cat.β-肾上腺素能受体和α-肾上腺素能受体在猫睡眠-觉醒周期各阶段调节中的作用。
Brain Res. 1983 Oct 24;277(1):109-18. doi: 10.1016/0006-8993(83)90912-5.
6
Beta 1- and beta 2-adrenoceptor-mediated secretion of amylase from incubated rat parotid gland.β1和β2肾上腺素能受体介导的大鼠腮腺淀粉酶分泌（来自孵育的大鼠腮腺）
Acta Physiol Scand. 1984 Mar;120(3):429-35. doi: 10.1111/j.1748-1716.1984.tb07403.x.
7
Clinical experiences with prenalterol as an antidote to Beta-adrenoceptor blockade.普瑞特罗作为β-肾上腺素能受体阻滞剂解毒剂的临床经验。
Acta Med Scand Suppl. 1982;659:191-9. doi: 10.1111/j.0954-6820.1982.tb00847.x.
8
An assessment of the partial agonist activity of Ro 31-1118, flusoxolol and pindolol in man.罗 31-1118、氟索洛尔和吲哚洛尔在人体中的部分激动剂活性评估。
Br J Clin Pharmacol. 1987 Nov;24(5):571-80. doi: 10.1111/j.1365-2125.1987.tb03215.x.
9
Beta adrenergic influence on oesophageal peristalsis in man.β肾上腺素能对人体食管蠕动的影响。
Gut. 1986 Mar;27(3):260-6. doi: 10.1136/gut.27.3.260.
10
引用本文的文献
1
Extracorporeal treatment for poisoning to beta-adrenergic antagonists: systematic review and recommendations from the EXTRIP workgroup.体外治疗β-肾上腺素能拮抗剂中毒：EXTRIP 工作组的系统评价和建议。
Crit Care. 2021 Jun 10;25(1):201. doi: 10.1186/s13054-021-03585-7.
本文引用的文献
1
Electron-capture-gas chromatographic determination of atenolol in plasma and urine, using a simplified procedure with improved selectivity.采用简化且选择性提高的方法，通过电子捕获气相色谱法测定血浆和尿液中的阿替洛尔。
J Chromatogr. 1980 Jun 13;182(3-4):341-7. doi: 10.1016/s0378-4347(00)81483-8.
2
Atenolol disposition in young and elderly subjects.阿替洛尔在年轻和老年受试者体内的处置情况。
Br J Clin Pharmacol. 1982 Feb;13(2):235-7. doi: 10.1111/j.1365-2125.1982.tb01364.x.
3
Prenalterol as an antidote to massive doses of metoprolol--a cardiovascular study in the dog.普瑞纳洛尔作为大剂量美托洛尔的解毒剂——一项在犬类中的心血管研究。
Acta Med Scand Suppl. 1982;659:71-88. doi: 10.1111/j.0954-6820.1982.tb00837.x.
4
Pharmacokinetics of oral propranolol in chronic renal disease.慢性肾病患者口服普萘洛尔的药代动力学
Clin Pharmacol Ther. 1974 Nov;16(5 Part 1):761-9. doi: 10.1002/cpt1974165part1761.
5
The disposition of propranolol. 3. Decreased half-life and volume of distribution as a result of plasma binding in man, monkey, dog and rat.普萘洛尔的处置。3. 由于人、猴、狗和大鼠体内的血浆结合作用，半衰期和分布容积降低。
J Pharmacol Exp Ther. 1973 Jul;186(1):114-22.
6
Clinical pharmacokinetics of beta-adrenoreceptor blocking drugs.β-肾上腺素受体阻断药的临床药代动力学
Clin Pharmacokinet. 1976;1(4):233-63. doi: 10.2165/00003088-197601040-00001.
7
Clinical pharmacologic observations on atenolol, a beta-adrenoceptor blocker.β-肾上腺素能受体阻滞剂阿替洛尔的临床药理学观察
Clin Pharmacol Ther. 1976 Nov;20(5):524-34. doi: 10.1002/cpt1976205524.
Zotero 插件